Prognostic value of the post-exercise heart rate recovery and BHDE-index in chronic obstructive pulmonary disease

The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascul...

Full description

Saved in:
Bibliographic Details
Published inBMC pulmonary medicine Vol. 23; no. 1; pp. 263 - 8
Main Authors Chen, Shih-Yu, Huang, Chun-Kai, Wu, Chia-Ling, Peng, Hui-Chuan, Yu, Chong-Jen, Chien, Jung-Yien
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 17.07.2023
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascular dysfunction is associated with poor clinical outcomes in COPD, we conducted a novel BHDE-index by replacing spirometry with post-exercise heart rate recovery (HRR, H) and evaluated its predictive performance in this observational study. From January 2019 to December 2019, enrolled patients were analyzed as a derivation cohort for the setup of the model. This model was verified in another group of patients generated between January 2020 and December 2020, as the validation cohort. The post exercise HRR was defined as the difference of heart rate immediately after and 1 min after test cessation. A total of 447 patients with COPD were enrolled. Patients with abnormal HRR were older, with more severe airway obstruction, severe airway symptoms, faster resting heart rate, shorter 6-min walk distance and higher frequency of severe acute exacerbation in previous one year. The prediction performance of the BHDE-index for one-year severe COPD exacerbation was similar to that of the BODE-index in both the derivation and validation groups [area under the receiver operating characteristic curve (AUROC) 0.76 vs. 0.75, p = 0.369; AUROC 0.74 vs. 0.79, p = 0.05]. The prediction performance for 1 year mortality was also similar between BHDE-index and BODE-index in both cohorts [AUROC 0.80 vs. 0.77, p = 0.564; 0.76 vs. 0.70, p = 0.234]. Univariate and multivariate analyses also showed that the BHDE-index was an independent and important predictor of annual severe COPD exacerbation in the derivation and validation cohorts. The BHDE-index is a good and easy-to-perform prediction model for the risk of severe acute exacerbation and 1-year mortality in COPD wherever spirometry results are unavailable.
AbstractList Background The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascular dysfunction is associated with poor clinical outcomes in COPD, we conducted a novel BHDE-index by replacing spirometry with post-exercise heart rate recovery (HRR, H) and evaluated its predictive performance in this observational study. Methods From January 2019 to December 2019, enrolled patients were analyzed as a derivation cohort for the setup of the model. This model was verified in another group of patients generated between January 2020 and December 2020, as the validation cohort. The post exercise HRR was defined as the difference of heart rate immediately after and 1 min after test cessation. Results A total of 447 patients with COPD were enrolled. Patients with abnormal HRR were older, with more severe airway obstruction, severe airway symptoms, faster resting heart rate, shorter 6-min walk distance and higher frequency of severe acute exacerbation in previous one year. The prediction performance of the BHDE-index for one-year severe COPD exacerbation was similar to that of the BODE-index in both the derivation and validation groups [area under the receiver operating characteristic curve (AUROC) 0.76 vs. 0.75, p = 0.369; AUROC 0.74 vs. 0.79, p = 0.05]. The prediction performance for 1 year mortality was also similar between BHDE-index and BODE-index in both cohorts [AUROC 0.80 vs. 0.77, p = 0.564; 0.76 vs. 0.70, p = 0.234]. Univariate and multivariate analyses also showed that the BHDE-index was an independent and important predictor of annual severe COPD exacerbation in the derivation and validation cohorts. Conclusions The BHDE-index is a good and easy-to-perform prediction model for the risk of severe acute exacerbation and 1-year mortality in COPD wherever spirometry results are unavailable. Keywords: Pulmonary rehabilitation, Chronic obstructive pulmonary disease, Pulmonary function, Heart rate recovery
BackgroundThe BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascular dysfunction is associated with poor clinical outcomes in COPD, we conducted a novel BHDE-index by replacing spirometry with post-exercise heart rate recovery (HRR, H) and evaluated its predictive performance in this observational study.MethodsFrom January 2019 to December 2019, enrolled patients were analyzed as a derivation cohort for the setup of the model. This model was verified in another group of patients generated between January 2020 and December 2020, as the validation cohort. The post exercise HRR was defined as the difference of heart rate immediately after and 1 min after test cessation.ResultsA total of 447 patients with COPD were enrolled. Patients with abnormal HRR were older, with more severe airway obstruction, severe airway symptoms, faster resting heart rate, shorter 6-min walk distance and higher frequency of severe acute exacerbation in previous one year. The prediction performance of the BHDE-index for one-year severe COPD exacerbation was similar to that of the BODE-index in both the derivation and validation groups [area under the receiver operating characteristic curve (AUROC) 0.76 vs. 0.75, p = 0.369; AUROC 0.74 vs. 0.79, p = 0.05]. The prediction performance for 1 year mortality was also similar between BHDE-index and BODE-index in both cohorts [AUROC 0.80 vs. 0.77, p = 0.564; 0.76 vs. 0.70, p = 0.234]. Univariate and multivariate analyses also showed that the BHDE-index was an independent and important predictor of annual severe COPD exacerbation in the derivation and validation cohorts.ConclusionsThe BHDE-index is a good and easy-to-perform prediction model for the risk of severe acute exacerbation and 1-year mortality in COPD wherever spirometry results are unavailable.
The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascular dysfunction is associated with poor clinical outcomes in COPD, we conducted a novel BHDE-index by replacing spirometry with post-exercise heart rate recovery (HRR, H) and evaluated its predictive performance in this observational study.BACKGROUNDThe BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascular dysfunction is associated with poor clinical outcomes in COPD, we conducted a novel BHDE-index by replacing spirometry with post-exercise heart rate recovery (HRR, H) and evaluated its predictive performance in this observational study.From January 2019 to December 2019, enrolled patients were analyzed as a derivation cohort for the setup of the model. This model was verified in another group of patients generated between January 2020 and December 2020, as the validation cohort. The post exercise HRR was defined as the difference of heart rate immediately after and 1 min after test cessation.METHODSFrom January 2019 to December 2019, enrolled patients were analyzed as a derivation cohort for the setup of the model. This model was verified in another group of patients generated between January 2020 and December 2020, as the validation cohort. The post exercise HRR was defined as the difference of heart rate immediately after and 1 min after test cessation.A total of 447 patients with COPD were enrolled. Patients with abnormal HRR were older, with more severe airway obstruction, severe airway symptoms, faster resting heart rate, shorter 6-min walk distance and higher frequency of severe acute exacerbation in previous one year. The prediction performance of the BHDE-index for one-year severe COPD exacerbation was similar to that of the BODE-index in both the derivation and validation groups [area under the receiver operating characteristic curve (AUROC) 0.76 vs. 0.75, p = 0.369; AUROC 0.74 vs. 0.79, p = 0.05]. The prediction performance for 1 year mortality was also similar between BHDE-index and BODE-index in both cohorts [AUROC 0.80 vs. 0.77, p = 0.564; 0.76 vs. 0.70, p = 0.234]. Univariate and multivariate analyses also showed that the BHDE-index was an independent and important predictor of annual severe COPD exacerbation in the derivation and validation cohorts.RESULTSA total of 447 patients with COPD were enrolled. Patients with abnormal HRR were older, with more severe airway obstruction, severe airway symptoms, faster resting heart rate, shorter 6-min walk distance and higher frequency of severe acute exacerbation in previous one year. The prediction performance of the BHDE-index for one-year severe COPD exacerbation was similar to that of the BODE-index in both the derivation and validation groups [area under the receiver operating characteristic curve (AUROC) 0.76 vs. 0.75, p = 0.369; AUROC 0.74 vs. 0.79, p = 0.05]. The prediction performance for 1 year mortality was also similar between BHDE-index and BODE-index in both cohorts [AUROC 0.80 vs. 0.77, p = 0.564; 0.76 vs. 0.70, p = 0.234]. Univariate and multivariate analyses also showed that the BHDE-index was an independent and important predictor of annual severe COPD exacerbation in the derivation and validation cohorts.The BHDE-index is a good and easy-to-perform prediction model for the risk of severe acute exacerbation and 1-year mortality in COPD wherever spirometry results are unavailable.CONCLUSIONSThe BHDE-index is a good and easy-to-perform prediction model for the risk of severe acute exacerbation and 1-year mortality in COPD wherever spirometry results are unavailable.
The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascular dysfunction is associated with poor clinical outcomes in COPD, we conducted a novel BHDE-index by replacing spirometry with post-exercise heart rate recovery (HRR, H) and evaluated its predictive performance in this observational study. From January 2019 to December 2019, enrolled patients were analyzed as a derivation cohort for the setup of the model. This model was verified in another group of patients generated between January 2020 and December 2020, as the validation cohort. The post exercise HRR was defined as the difference of heart rate immediately after and 1 min after test cessation. A total of 447 patients with COPD were enrolled. Patients with abnormal HRR were older, with more severe airway obstruction, severe airway symptoms, faster resting heart rate, shorter 6-min walk distance and higher frequency of severe acute exacerbation in previous one year. The prediction performance of the BHDE-index for one-year severe COPD exacerbation was similar to that of the BODE-index in both the derivation and validation groups [area under the receiver operating characteristic curve (AUROC) 0.76 vs. 0.75, p = 0.369; AUROC 0.74 vs. 0.79, p = 0.05]. The prediction performance for 1 year mortality was also similar between BHDE-index and BODE-index in both cohorts [AUROC 0.80 vs. 0.77, p = 0.564; 0.76 vs. 0.70, p = 0.234]. Univariate and multivariate analyses also showed that the BHDE-index was an independent and important predictor of annual severe COPD exacerbation in the derivation and validation cohorts. The BHDE-index is a good and easy-to-perform prediction model for the risk of severe acute exacerbation and 1-year mortality in COPD wherever spirometry results are unavailable.
The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascular dysfunction is associated with poor clinical outcomes in COPD, we conducted a novel BHDE-index by replacing spirometry with post-exercise heart rate recovery (HRR, H) and evaluated its predictive performance in this observational study. From January 2019 to December 2019, enrolled patients were analyzed as a derivation cohort for the setup of the model. This model was verified in another group of patients generated between January 2020 and December 2020, as the validation cohort. The post exercise HRR was defined as the difference of heart rate immediately after and 1 min after test cessation. A total of 447 patients with COPD were enrolled. Patients with abnormal HRR were older, with more severe airway obstruction, severe airway symptoms, faster resting heart rate, shorter 6-min walk distance and higher frequency of severe acute exacerbation in previous one year. The prediction performance of the BHDE-index for one-year severe COPD exacerbation was similar to that of the BODE-index in both the derivation and validation groups [area under the receiver operating characteristic curve (AUROC) 0.76 vs. 0.75, p = 0.369; AUROC 0.74 vs. 0.79, p = 0.05]. The prediction performance for 1 year mortality was also similar between BHDE-index and BODE-index in both cohorts [AUROC 0.80 vs. 0.77, p = 0.564; 0.76 vs. 0.70, p = 0.234]. Univariate and multivariate analyses also showed that the BHDE-index was an independent and important predictor of annual severe COPD exacerbation in the derivation and validation cohorts. The BHDE-index is a good and easy-to-perform prediction model for the risk of severe acute exacerbation and 1-year mortality in COPD wherever spirometry results are unavailable.
Abstract Background The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD. However, when spirometry was restricted to prevent cross-infection such as COVID-19 pandemic, a modified index would be needed. Because cardiovascular dysfunction is associated with poor clinical outcomes in COPD, we conducted a novel BHDE-index by replacing spirometry with post-exercise heart rate recovery (HRR, H) and evaluated its predictive performance in this observational study. Methods From January 2019 to December 2019, enrolled patients were analyzed as a derivation cohort for the setup of the model. This model was verified in another group of patients generated between January 2020 and December 2020, as the validation cohort. The post exercise HRR was defined as the difference of heart rate immediately after and 1 min after test cessation. Results A total of 447 patients with COPD were enrolled. Patients with abnormal HRR were older, with more severe airway obstruction, severe airway symptoms, faster resting heart rate, shorter 6-min walk distance and higher frequency of severe acute exacerbation in previous one year. The prediction performance of the BHDE-index for one-year severe COPD exacerbation was similar to that of the BODE-index in both the derivation and validation groups [area under the receiver operating characteristic curve (AUROC) 0.76 vs. 0.75, p = 0.369; AUROC 0.74 vs. 0.79, p = 0.05]. The prediction performance for 1 year mortality was also similar between BHDE-index and BODE-index in both cohorts [AUROC 0.80 vs. 0.77, p = 0.564; 0.76 vs. 0.70, p = 0.234]. Univariate and multivariate analyses also showed that the BHDE-index was an independent and important predictor of annual severe COPD exacerbation in the derivation and validation cohorts. Conclusions The BHDE-index is a good and easy-to-perform prediction model for the risk of severe acute exacerbation and 1-year mortality in COPD wherever spirometry results are unavailable.
ArticleNumber 263
Audience Academic
Author Chien, Jung-Yien
Huang, Chun-Kai
Peng, Hui-Chuan
Wu, Chia-Ling
Yu, Chong-Jen
Chen, Shih-Yu
Author_xml – sequence: 1
  givenname: Shih-Yu
  surname: Chen
  fullname: Chen, Shih-Yu
– sequence: 2
  givenname: Chun-Kai
  surname: Huang
  fullname: Huang, Chun-Kai
– sequence: 3
  givenname: Chia-Ling
  surname: Wu
  fullname: Wu, Chia-Ling
– sequence: 4
  givenname: Hui-Chuan
  surname: Peng
  fullname: Peng, Hui-Chuan
– sequence: 5
  givenname: Chong-Jen
  surname: Yu
  fullname: Yu, Chong-Jen
– sequence: 6
  givenname: Jung-Yien
  surname: Chien
  fullname: Chien, Jung-Yien
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37461073$$D View this record in MEDLINE/PubMed
BookMark eNptkktv1DAURiNURB_wB1ggS2zYpPgRx54VaktLK1WCBawtx76Z8ShjT-1kVP49dzpt6SBkWbFujo99re-4OogpQlW9Z_SUMd1-LozrGa0pFzilVLV6VR2xRrGaN2178GJ9WB2XsqSUKS3Fm-pQqKZlVImj6u5HTvOYyhgc2dhhApJ6Mi6ArLFWwz1kFwqQBdg8kmxHIBlc2kD-TWz05Pz662Udood7EiJxi5wiilJXxjy5MWzQMw2rFC3yHkW2wNvqdW-HAu8evyfVr6vLnxfX9e33bzcXZ7e1k0zi0dq1HRWOWuds1_eedozPrLBO9zMFFkBDQxXvuW86QZngrVO905K3vPNOiJPqZuf1yS7NOocVXsIkG8xDIeW5wZ6CG8BI2jYCJ3MWGkm9VtZLYEClUK3WDl1fdq711K3AO4hjtsOedP9PDAszTxvDqJCCC42GT4-GnO4mKKNZheJgGGyENBXDtZjxRs2URPTjP-gyTTniW20pvb2Rav9Sc4sdhNgnPNhtpeZMSRyN0Ayp0_9QODysgsM49QHrexs-vOz0ucWnxCDAd4DLqZQM_TPCqNnG0uxiaTCW5iGWRok_Y9fU7Q
Cites_doi 10.1056/NEJM199910283411804
10.1136/thoraxjnl-2018-211855
10.1164/rccm.201610-2037ED
10.1016/S2213-2600(20)30246-0
10.1183/09031936.00072212
10.1378/chest.106.5.1432
10.1007/s00408-017-0027-0
10.1164/rccm.201604-0690SO
10.1586/erc.11.149
10.1161/JAHA.117.008341
10.1016/j.rmed.2004.11.012
10.1164/rccm.201607-1330OC
10.1183/13993003.00918-2020
10.1016/S0140-6736(17)31222-9
10.2147/COPD.S329454
10.1164/rccm.201810-1860SO
10.1164/ajrccm.166.1.at1102
10.2147/COPD.S311572
10.1183/16000617.0057-2018
10.1164/rccm.202009-3533SO
10.1378/chest.125.4.1286
10.1056/NEJMoa021322
ContentType Journal Article
Copyright 2023. The Author(s).
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID AAYXX
CITATION
NPM
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12890-023-02557-7
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic
PubMed


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2466
EndPage 8
ExternalDocumentID oai_doaj_org_article_506430641cae450d87ad5e1e0537688c
PMC10353238
A757574381
37461073
10_1186_s12890_023_02557_7
Genre Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GrantInformation_xml – fundername: National Taiwan University Hospital
  grantid: 112-S0108
– fundername: Ministry of Science and Technology, Taiwan
  grantid: MOST 111-2314-B-002 -201 -MY3
– fundername: National Taiwan University Hospital Hsin-Chu Branch
  grantid: 112-HCH-016
– fundername: ;
  grantid: 112-HCH-016
– fundername: ;
  grantid: MOST 111-2314-B-002 -201 -MY3
– fundername: ;
  grantid: 112-S0108
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
NPM
PMFND
3V.
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c515t-e8c6b03c0accabffd0b129a3ac8f97eaee8e4072f2d4b301326c7fc85262bdc33
IEDL.DBID M48
ISSN 1471-2466
IngestDate Wed Aug 27 01:31:37 EDT 2025
Thu Aug 21 18:36:27 EDT 2025
Fri Jul 11 10:34:14 EDT 2025
Sat Jul 26 00:30:53 EDT 2025
Tue Jun 17 21:48:08 EDT 2025
Tue Jun 10 21:24:18 EDT 2025
Thu Apr 03 07:25:20 EDT 2025
Tue Jul 01 02:40:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Chronic obstructive pulmonary disease
Heart rate recovery
Pulmonary function
Pulmonary rehabilitation
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-e8c6b03c0accabffd0b129a3ac8f97eaee8e4072f2d4b301326c7fc85262bdc33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/2838768876?pq-origsite=%requestingapplication%
PMID 37461073
PQID 2838768876
PQPubID 44785
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_506430641cae450d87ad5e1e0537688c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10353238
proquest_miscellaneous_2839247975
proquest_journals_2838768876
gale_infotracmisc_A757574381
gale_infotracacademiconefile_A757574381
pubmed_primary_37461073
crossref_primary_10_1186_s12890_023_02557_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-07-17
PublicationDateYYYYMMDD 2023-07-17
PublicationDate_xml – month: 07
  year: 2023
  text: 2023-07-17
  day: 17
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC pulmonary medicine
PublicationTitleAlternate BMC Pulm Med
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 2557_CR1
BR Celli (2557_CR7) 2004; 350
ATS statement (2557_CR19) 2002; 166
D Zhao (2557_CR16) 2021; 16
M Volterrani (2557_CR22) 1994; 106
SL Cheng (2557_CR17) 2021; 16
RA Stockley (2557_CR6) 2019; 199
DA Rodriguez (2557_CR14) 2017; 195
JD Keene (2557_CR5) 2017; 195
2557_CR9
2557_CR20
MT Jensen (2557_CR23) 2013; 42
S Okutucu (2557_CR13) 2011; 9
SL Cheng (2557_CR25) 2015; 10
DMG Halpin (2557_CR2) 2021; 203
N Seshadri (2557_CR21) 2004; 125
2557_CR18
CR Cole (2557_CR11) 1999; 341
2557_CR12
JM Fermont (2557_CR24) 2019; 74
KF Rabe (2557_CR3) 2017; 389
S Roversi (2557_CR10) 2016; 194
GC Donaldson (2557_CR4) 2017; 195
M Lacasse (2557_CR15) 2005; 99
JH Hull (2557_CR8) 2020; 8
References_xml – volume: 341
  start-page: 1351
  issue: 18
  year: 1999
  ident: 2557_CR11
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199910283411804
– volume: 74
  start-page: 439
  issue: 5
  year: 2019
  ident: 2557_CR24
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2018-211855
– ident: 2557_CR18
– volume: 195
  start-page: 415
  issue: 4
  year: 2017
  ident: 2557_CR4
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201610-2037ED
– volume: 8
  start-page: 666
  issue: 7
  year: 2020
  ident: 2557_CR8
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30246-0
– volume: 42
  start-page: 341
  issue: 2
  year: 2013
  ident: 2557_CR23
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00072212
– volume: 106
  start-page: 1432
  issue: 5
  year: 1994
  ident: 2557_CR22
  publication-title: Chest
  doi: 10.1378/chest.106.5.1432
– volume: 195
  start-page: 463
  issue: 4
  year: 2017
  ident: 2557_CR14
  publication-title: Lung
  doi: 10.1007/s00408-017-0027-0
– volume: 194
  start-page: 1319
  issue: 11
  year: 2016
  ident: 2557_CR10
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201604-0690SO
– volume: 9
  start-page: 1417
  issue: 11
  year: 2011
  ident: 2557_CR13
  publication-title: Expert Rev Cardiovasc Ther
  doi: 10.1586/erc.11.149
– ident: 2557_CR12
  doi: 10.1161/JAHA.117.008341
– volume: 10
  start-page: 2459
  year: 2015
  ident: 2557_CR25
  publication-title: Int J Chron Obstruct Pulmon Dis
– volume: 99
  start-page: 877
  issue: 7
  year: 2005
  ident: 2557_CR15
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2004.11.012
– volume: 195
  start-page: 473
  issue: 4
  year: 2017
  ident: 2557_CR5
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201607-1330OC
– ident: 2557_CR20
  doi: 10.1183/13993003.00918-2020
– volume: 389
  start-page: 1931
  issue: 10082
  year: 2017
  ident: 2557_CR3
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)31222-9
– volume: 16
  start-page: 2869
  year: 2021
  ident: 2557_CR17
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S329454
– volume: 199
  start-page: 1195
  issue: 10
  year: 2019
  ident: 2557_CR6
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201810-1860SO
– volume: 166
  start-page: 111
  issue: 1
  year: 2002
  ident: 2557_CR19
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.166.1.at1102
– volume: 16
  start-page: 2545
  year: 2021
  ident: 2557_CR16
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S311572
– ident: 2557_CR9
  doi: 10.1183/16000617.0057-2018
– ident: 2557_CR1
– volume: 203
  start-page: 24
  issue: 1
  year: 2021
  ident: 2557_CR2
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.202009-3533SO
– volume: 125
  start-page: 1286
  issue: 4
  year: 2004
  ident: 2557_CR21
  publication-title: Chest
  doi: 10.1378/chest.125.4.1286
– volume: 350
  start-page: 1005
  issue: 10
  year: 2004
  ident: 2557_CR7
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa021322
SSID ssj0017853
Score 2.3261986
Snippet The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in COPD....
Background The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in...
BackgroundThe BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict outcomes in...
Abstract Background The BODE index, consisting of body mass index (B), airflow obstruction (O), dyspnea score (D), and exercise capacity (E), can predict...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 263
SubjectTerms Aerosols
Analysis
Body mass index
Care and treatment
Chronic obstructive pulmonary disease
Clinical outcomes
COVID-19
Cross-infection
Dyspnea
Health aspects
Heart beat
Heart rate
Heart rate recovery
Lung diseases
Lung diseases, Obstructive
Measurement
Mortality
Obstructive lung disease
Pay for performance
Physical training
Prediction models
Prognosis
Pulmonary function
Pulmonary function tests
Pulmonary rehabilitation
Pulmonology
Respiration
Respiratory tract
Spirometry
Survival analysis
Walking
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ1Nb9QwEIYt1APigvgmtCAjIXFAVpM49jjHFlqtkIo4UKk3y18RlVBSaIvUf8-M46w24sCFa-zdJJ5x5p2M85ixdy2oJnZRia6PWnRdLUUfOyf6OkrwUevo6IX-2Re9Oe8-X6iLna2-aE3YjAeeB-6QgGqkkpvgUqfqaMBFlZqUOSTGBHr6YsxbkqlSPwCMQssnMkYfXjdUTxMYnwRpaBCwCkOZ1v_3M3knKK0XTO5EoNNH7GGRjvxovuTH7F4an7D7Z6U4_pT9_PpromVz2MyJ4Z34NHDUd_wKj4llbyVOW1jfcCJEcMqG0ZXvuBsjP958OhEZnsgvRx5maC6ffCHM_sb_uf2BTuuwfynrPGPnpyffPm5E2VFBBNQteCoTtK9lqB0azg9DrD3GeyddMEMPyaVkEhHThjZ2XlIZRgcYglGtbn0MUj5ne-M0ppeMp6YfALxLhBIFQ5g-aFTCbKrxgCK4Yh-WAbZXMzjD5oTDaDubw6I5bDaHhYodkw22PQl6nQ-gK9jiCvZfrlCx92RBS1MTzRRc-cIAL5ggV_YIUJsCMc0qdrDqiVMqrJsXH7BlSl9b1GGGTgO6Ym-3zfRLWqY2puk298F8FnpQFXsxu8z2liQQ2h5kxczKmVb3vG4ZL79n4HdTSyVRW736H6O0zx60eSIQHPSA7aETpdcorG78mzyH_gAfDR8e
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3Ni9UwEMCDriBexG-rq0QQPEjYtmkz6Ul2dZeHsOLBhXcL-aouSPt2367gf-9Mmj63CF6b9HNmMjNJ-hvG3tbQVqEJrWi6oETTlFJ0obGiK4MEF5QKlib0T7-o1Vnzed2u84TbNm-rnMfENFCH0dMc-QG6QTRcNAn1YXMhqGoUra7mEhq32R1Cl9GWLljvEi4qPC_nH2W0OthWtKom0EsJiqRBwMIZJWb_vyPzDde03DZ5ww-dPGD3cwDJDyeJP2S34vCI3T3NS-SP2cXXy5E2z2EzJ5J35GPPMcrjGzwm5gpLnApZX3HiRHDKiVGhf3M7BH60-nQsEkKRnw_cT-hcPrrMmf2F17n-id_CYv-8uPOEnZ0cf_u4ErmugvAYveCttFeulL60KD7X96F06PWttF73HUQbo47ETevr0DhJizHKQ-91W6vaBS_lU7Y3jEN8znisuh7A2UhAUdAE64OqjZhTVQ4wFC7Y-_kDm82EzzAp7dDKTOIwKA6TxGGgYEckg11PQl-nA-Pld5MtyRBhj9KmytvYtGXQYEMbq5jANFr7gr0jCRoyUBSTt_k_A3xgQl2ZQ8AIFYhsVrD9RU80LL9snnXAZMPemr9qWLA3u2Y6kzarDXG8Tn0wq4UO2oI9m1Rm90oSCHAPsmB6oUyLd162DOc_Eva7KmUrMcJ68f_nesnu1UnFCf65z_ZQPeIrDJyu3OtkHX8AB4AX2Q
  priority: 102
  providerName: ProQuest
Title Prognostic value of the post-exercise heart rate recovery and BHDE-index in chronic obstructive pulmonary disease
URI https://www.ncbi.nlm.nih.gov/pubmed/37461073
https://www.proquest.com/docview/2838768876
https://www.proquest.com/docview/2839247975
https://pubmed.ncbi.nlm.nih.gov/PMC10353238
https://doaj.org/article/506430641cae450d87ad5e1e0537688c
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZ5QOml9F236aJCoYei1k-NfCgl225YChtC6MLSi5AlOQ0EO9kkpfn3nZHtbUxz6MUHS7ZszzfWNx75G8beplAkLneFyEsnRZ7HmShdbkQZuwwqJ6Uz9EF_cSjny_zbqlhtsaHcUf8AL-8M7aie1HJ99uH3xc1ndPhPweGV_HiZULZM4OwjiCGDgG22izMTkKMu8r9ZBVBBlTLBF7JIcymHn2juPMdoogp6_v--tW9NW-MllbfmqIOH7EFPLvl-h4ZHbMs3j9m9RZ8-f8IujtYtLazDZk4q3563NUcGyM9xnxiqL3Eqcn3FSUOCU7yMYL_hpnF8Ov86E0FekZ823Hayuryteg3aX3ie6zOEtcH-feLnKVsezL5_mYu-5oKwyGxwKGVlFWc2Nmjaqq5dXCEjMJmxqi7BG--VJ021OnV5lVGiRlqorSpSmVbOZtkzttO0jX_BuE_KGqAynsRGQZGQHySFx3grqQBpcsTeDw9Yn3fSGjqEJErqzhwazaGDOTREbEo22PQkWeywo12f6N7LNKnvUUiVWOPzInYKjCt84oNojVI2Yu_IgprghGaypv8HAS-YZLD0PiB7BVI9i9jeqCc6nR03DxjQA2Y1MjVFw4CM2JtNMx1JC9ka316HPhjxQglFxJ53kNncUgYkfg9ZxNQITKN7Hrc0pz-DJHgSZ0WG7Ovlfwz8it1PA85JHXSP7SBG_GtkVlfVhG3DCiZsdzo7PDqehO8Tk-BCuD2e_vgDSi4jVQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VWwm4IN4EChgJxAFZTeIkdg4IdelWW9pdVaiVejOO7UAllGy7W1D_FL-RmTyWRkjcerWdyPa8PfY3AG9imUYucSlPcpfxJAkFz11ieB46IQuXZc7Qgf5snk1Pks-n6ekG_O7fwtC1yl4nNora1ZbOyLfRDKLgokhkHxfnnKpGUXa1L6HRssWBv_qFIdvyw_4u0vdtHO9Njj9NeVdVgFu03Svulc2KUNjQ4OSLsnRhgTbPCGNVmUtvvFeeUMPK2CWFoFREZmVpVRpnceEsHYCiyt9MBIYyI9gcT-ZHX9Z5C4nWr3-ao7LtZUR5PI52kZPvLrkcmL-mSsC_tuCaMRxe1Lxm-fbuwd3OZWU7LY_dhw1fPYBbsy4p_xDOjy5quq6H3Yywwz2rS4Z-JVtgG-9rOjEqnb1ihEzBKApHEbpipnJsPN2d8Aa0kZ1VzLZgvawuOmTbn_ifyx-4-wbHd-mkR3ByI3v-GEZVXfmnwHyUl1IWxhOEqVQEDyij1GMUFxUSne8A3vcbrBctYIduAh2V6ZYcGsmhG3JoGcCYaLAeSWDbTUN98U13sqsJ048Ctcgan6ShU9K41Ee-gcJRygbwjiioSSUgmazpXjbghAlcS-9I9IklYakFsDUYiaJsh909D-hOlSz1X8YP4PW6m76k63GVry-bMRhHy1ymATxpWWa9JCEJUl-KANSAmQZrHvZUZ98boPEoFKlAn-7Z_-f1Cm5Pj2eH-nB_fvAc7sQNuxP06BaMkFX8C3TbVsXLTlYYfL1p8fwDC4lYTA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+value+of+the+post-exercise+heart+rate+recovery+and+BHDE-index+in+chronic+obstructive+pulmonary+disease&rft.jtitle=BMC+pulmonary+medicine&rft.au=Chen%2C+Shih-Yu&rft.au=Huang%2C+Chun-Kai&rft.au=Wu%2C+Chia-Ling&rft.au=Peng%2C+Hui-Chuan&rft.date=2023-07-17&rft.issn=1471-2466&rft.eissn=1471-2466&rft.volume=23&rft.issue=1&rft.spage=263&rft_id=info:doi/10.1186%2Fs12890-023-02557-7&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon